TNF-Based Isolated Limb Perfusion Followed by Consolidation Biotherapy with Systemic Low-dose Interferon Alpha 2b in Patients with In-transit Melanoma Metastases: A Pilot Trial

2008 ◽  
Vol 15 (4) ◽  
pp. 1218-1223 ◽  
Author(s):  
Carlo Riccardo Rossi ◽  
Francesco Russano ◽  
Simone Mocellin ◽  
Vanna Chiarion-Sileni ◽  
Mirto Foletto ◽  
...  
Keyword(s):  
Interferon Alpha ◽  
Low Dose ◽  
Pilot Trial ◽  
Isolated Limb Perfusion ◽  
Interferon Alpha 2B ◽  
Limb Perfusion ◽  
Melanoma Metastases ◽  
In Transit

Long-Term Results of Melphalan-Based Isolated Limb Perfusion With or Without Low-Dose TNF for In-Transit Melanoma Metastases

2010 ◽  
Vol 17 (11) ◽  
pp. 3000-3007 ◽  
Author(s):  
Carlo Riccardo Rossi ◽  
Sandro Pasquali ◽  
Simone Mocellin ◽  
Antonella Vecchiato ◽  
Luca Giovanni Campana ◽  
...  
Keyword(s):  
Low Dose ◽  
Isolated Limb Perfusion ◽  
Long Term Results ◽  
Limb Perfusion ◽  
Melanoma Metastases ◽  
In Transit

scholarly journals 20 Years Experience of TNF-Based Isolated Limb Perfusion for In-Transit Melanoma Metastases: TNF Dose Matters

2011 ◽  
Vol 19 (2) ◽  
pp. 627-635 ◽  
Author(s):  
Jan P. Deroose ◽  
Alexander M. M. Eggermont ◽  
Albertus N. van Geel ◽  
Johannes H. W. de Wilt ◽  
Jacobus W. A. Burger ◽  
...  
Keyword(s):  
Isolated Limb Perfusion ◽  
Limb Perfusion ◽  
Melanoma Metastases ◽  
In Transit

scholarly journals Isolated limb perfusion for in-transit melanoma metastases: Melphalan or TNF-melphalan perfusion?

2014 ◽  
Vol 109 (4) ◽  
pp. 338-347 ◽  
Author(s):  
Harald J. Hoekstra ◽  
Kelly Veerman ◽  
Robert J. van Ginkel
Keyword(s):  
Isolated Limb Perfusion ◽  
Limb Perfusion ◽  
Melanoma Metastases ◽  
In Transit
Sign in / Sign up

Export Citation Format

Share Document